These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study. Pikkarainen E, Lehtonen-Veromaa M, Möttönen T, Kautiainen H, Viikari J. Contraception; 2008 Sep; 78(3):226-31. PubMed ID: 18692613 [Abstract] [Full Text] [Related]
11. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density. Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR. Maturitas; 2006 May 20; 54(2):176-80. PubMed ID: 16332417 [Abstract] [Full Text] [Related]
12. [Cardiovascular risks of oral contraceptives: dose-response relationship]. Kelleher CC. Contracept Fertil Sex (Paris); 1991 Apr 20; 19(4):285-8. PubMed ID: 12343220 [Abstract] [Full Text] [Related]
13. Current perspectives on combination oral contraceptives. Smith MA, Youngkin EQ. Clin Pharm; 1984 Apr 20; 3(5):485-96. PubMed ID: 6386284 [Abstract] [Full Text] [Related]
16. Bone health in estrogen-free contraception. Hadji P, Colli E, Regidor PA. Osteoporos Int; 2019 Dec 20; 30(12):2391-2400. PubMed ID: 31446440 [Abstract] [Full Text] [Related]
19. Contraception for the perimenopausal patient. Upton GV. Obstet Gynecol Clin North Am; 1987 Mar 20; 14(1):207-27. PubMed ID: 3306520 [Abstract] [Full Text] [Related]
20. The effects of hormonal contraceptives on bone turnover markers and bone health. Herrmann M, Seibel MJ. Clin Endocrinol (Oxf); 2010 May 20; 72(5):571-83. PubMed ID: 19740118 [Abstract] [Full Text] [Related] Page: [Next] [New Search]